These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 24632933)

  • 1. Meningococcal serogroup B outbreaks and use of 4CMenB vaccine.
    Rose WE
    J Am Pharm Assoc (2003); 2014; 54(2):198-201. PubMed ID: 24632933
    [No Abstract]   [Full Text] [Related]  

  • 2. Outbreaks of meningococcal B infection and the 4CMenB vaccine: historical and future perspectives.
    Whelan J; Bambini S; Biolchi A; Brunelli B; Robert-Du Ry van Beest Holle M
    Expert Rev Vaccines; 2015 May; 14(5):713-36. PubMed ID: 25603916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Princeton University can import vaccine to combat meningitis outbreak.
    Clin Infect Dis; 2014 Feb; 58(3):i. PubMed ID: 24571006
    [No Abstract]   [Full Text] [Related]  

  • 4. Epidemiology and meningococcal serogroup distribution in the United States.
    Hershey JH; Hitchcock W
    Clin Pediatr (Phila); 2010 Jun; 49(6):519-24. PubMed ID: 20507868
    [No Abstract]   [Full Text] [Related]  

  • 5. The epidemiology and control of invasive meningococcal disease.
    Diaz PS
    Pediatr Infect Dis J; 1999 Jul; 18(7):633-4. PubMed ID: 10440442
    [No Abstract]   [Full Text] [Related]  

  • 6. [Group B meningococcal invasive infections: an unresolved public health problem].
    Crisinel PA; Posfay-Barbe KM
    Rev Med Suisse; 2011 Feb; 7(283):447-50. PubMed ID: 21452513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention and control of meningococcal outbreaks: The emerging role of serogroup B meningococcal vaccines.
    Oviedo-Orta E; Ahmed S; Rappuoli R; Black S
    Vaccine; 2015 Jul; 33(31):3628-35. PubMed ID: 26093201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In brief: prevention of meningococcus B disease.
    Med Lett Drugs Ther; 2013 Dec; 55(1431):97. PubMed ID: 24322662
    [No Abstract]   [Full Text] [Related]  

  • 9. The threat of meningococcal disease during the Hajj and Umrah mass gatherings: A comprehensive review.
    Yezli S
    Travel Med Infect Dis; 2018; 24():51-58. PubMed ID: 29751133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of vaccination on meningococcal epidemiology.
    Stefanelli P; Rezza G
    Hum Vaccin Immunother; 2016 Apr; 12(4):1051-5. PubMed ID: 26512927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The challenge of post-implementation surveillance for novel meningococcal vaccines.
    Snape MD; Medini D; Halperin SA; DeTora L; Drori J; Moxon ER
    Vaccine; 2012 May; 30 Suppl 2():B67-72. PubMed ID: 22230578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances towards the prevention of meningococcal B disease: a multidimensional story.
    Roderick M; Finn A
    J Infect; 2014 Jan; 68 Suppl 1():S76-82. PubMed ID: 24139188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel quadrivalent meningococcal A, C, W-135 and Y glycoconjugate vaccine for the broader protection of adolescents and adults.
    Pace D
    Future Microbiol; 2010 Nov; 5(11):1629-40. PubMed ID: 21133685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Group B meningococcal vaccine science and policy.
    Drysdale SB; Pollard AJ
    J Infect; 2015 Jun; 71 Suppl 1():S15-20. PubMed ID: 25917798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Changing Epidemiology of Meningococcal Disease.
    Cohn A; MacNeil J
    Infect Dis Clin North Am; 2015 Dec; 29(4):667-77. PubMed ID: 26610420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outbreak of invasive meningococcal disease in Goleniow County, northwest Poland, March 2009.
    Skoczyńska A; Wasko I; Kuch A; Gołebiewska A; Foryś M; Hryniewicz W
    Euro Surveill; 2010 Aug; 15(34):. PubMed ID: 20807486
    [No Abstract]   [Full Text] [Related]  

  • 17. MATS: Global coverage estimates for 4CMenB, a novel multicomponent meningococcal B vaccine.
    Medini D; Stella M; Wassil J
    Vaccine; 2015 May; 33(23):2629-36. PubMed ID: 25882169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine profile of 4CMenB: a four-component Neisseria meningitidis serogroup B vaccine.
    Esposito S; Principi N
    Expert Rev Vaccines; 2014 Feb; 13(2):193-202. PubMed ID: 24393061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Could the multicomponent meningococcal serogroup B vaccine (4CMenB) control Neisseria meningitidis capsular group X outbreaks in Africa?
    Hong E; Giuliani MM; Deghmane AE; Comanducci M; Brunelli B; Dull P; Pizza M; Taha MK
    Vaccine; 2013 Feb; 31(7):1113-6. PubMed ID: 23261039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meningococcal disease: risk for international travellers and vaccine strategies.
    Wilder-Smith A
    Travel Med Infect Dis; 2008 Jul; 6(4):182-6. PubMed ID: 18571105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.